We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+275.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Sector Composition

Rank Sector Weight
1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITE icon
1
Lumentum
LITE
$78B
$14.5M 5.42%
20,673
+15,003
+265% +$8.24M
AXTI icon
2
AXT Inc
AXTI
$5.07B
$13.3M 4.96%
233,563
-74,048
-24% -$2.45M
INTC icon
3
Intel
INTC
$527B
$12.1M 4.51%
274,389
+129,549
+89% +$5.94M
TSEM icon
4
Tower Semiconductor
TSEM
$28.6B
$11.9M 4.42%
+67,608
New +$9.09M
SNDK
5
Sandisk
SNDK
$223B
$9.07M 3.38%
14,280
-3,767
-21% -$2.13M
GLW icon
6
Corning
GLW
$137B
$8.03M 2.99%
59,088
+53,812
+1,020% +$6.49M
NVDA icon
7
NVIDIA
NVDA
$5.46T
$6.96M 2.6%
39,936
+23,594
+144% +$4.33M
MU icon
8
Micron Technology
MU
$1.07T
$5.59M 2.08%
16,550
+11,017
+199% +$4.32M
CIEN icon
9
Ciena
CIEN
$62.7B
$4.6M 1.71%
+11,838
New +$3.62M
VKTX icon
10
Viking Therapeutics
VKTX
$3.84B
$4.33M 1.61%
133,066
+42,552
+47% +$1.37M
TSM icon
11
TSMC
TSM
$2.23T
$4.22M 1.57%
12,486
+10,886
+680% +$3.75M
UTHR icon
12
United Therapeutics
UTHR
$21.5B
$4.09M 1.53%
6,902
+3,635
+111% +$1.81M
ALAB icon
13
Astera Labs
ALAB
$56B
$3.67M 1.37%
+33,516
New +$4.77M
COGT icon
14
Cogent Biosciences
COGT
$6.47B
$3.56M 1.33%
92,516
+45,017
+95% +$1.66M
MTSI icon
15
MACOM Technology Solutions
MTSI
$23.5B
$3.49M 1.3%
+15,694
New +$3.5M
JNJ icon
16
Johnson & Johnson
JNJ
$632B
$3.32M 1.24%
13,593
-4,115
-23% -$958K
TER icon
17
Teradyne
TER
$64.2B
$3.31M 1.23%
+11,152
New +$3.11M
COHR icon
18
Coherent
COHR
$64B
$3.27M 1.22%
13,738
+13,038
+1,863% +$2.99M
JAZZ icon
19
Jazz Pharmaceuticals
JAZZ
$16B
$3.01M 1.12%
15,905
+14,014
+741% +$2.45M
TEL icon
20
TE Connectivity
TEL
$62.2B
$2.83M 1.05%
+13,520
New +$2.98M
GOOG icon
21
Alphabet (Google) Class C
GOOG
$4.21T
$2.77M 1.03%
9,672
+1,603
+20% +$504K
NXE icon
22
NexGen Energy
NXE
$6.97B
$2.76M 1.03%
237,953
-5,576
-2% -$66.6K
MOD icon
23
Modine Manufacturing
MOD
$10.8B
$2.75M 1.02%
12,682
+8,947
+240% +$1.68M
ABVX
24
Abivax
ABVX
$10.6B
$2.54M 0.95%
22,838
-1,575
-6% -$186K
RVMD icon
25
Revolution Medicines
RVMD
$43.3B
$2.53M 0.94%
26,043
+8,506
+49% +$859K

Similar funds

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.